Clinical Documents

To edit the draft, click on the text box below.

×

Draft a comprehensive differential diagnosis for acute substernal chest pain in a 45-year-old male with hypertension and hyperlipidemia, diaphoresis, exertional onset, and normal initial ECG/troponin; include life-threatening causes first, key distinguishing features, and immediate diagnostic next steps.

Draft a detailed differential diagnosis for new-onset unilateral throbbing headache with visual aura and brief monocular vision loss in a 32-year-old female on oral contraceptives; include red-flag symptoms, stroke/TIA considerations, and recommended initial workup.

Draft an assessment and plan for stage-2 hypertension (BP 162/98) in an obese 52-year-old with suspected obstructive sleep apnea; include ASCVD risk estimate, lifestyle prescriptions, first-line pharmacotherapy with drug/dose/targets, baseline labs/monitoring, and 4–6 week follow-up.

Draft an assessment and plan for type 2 diabetes follow-up with A1c 9.2% on metformin 1,000 mg BID and eGFR 65; compare adding a GLP-1 receptor agonist vs an SGLT2 inhibitor, address weight loss goals, hypoglycemia education, vaccinations, and micro/macrovascular screening.

Draft a history and physical for a patient presenting with chest pain, including HPI using OLDCARTS, pertinent ROS, PMH/meds/allergies, FH/SH, focused cardiac/pulmonary exam, initial labs and imaging orders, prioritized differential, HEART score risk stratification, and early management.

Draft a history and physical for a new patient with progressive exertional dyspnea, orthopnea, and bilateral leg edema; include differential (heart failure, COPD, PE, anemia, renal disease), targeted exam maneuvers, and first-line diagnostics and management.

Draft a progress note for COPD follow-up two weeks after an acute exacerbation treated with prednisone and antibiotics; include symptom trajectory, CAT score (if available), inhaler technique/adherence, oxygen needs, spirometry plan, smoking cessation counseling, and return precautions.

Draft a progress note for post-operative day 2 after total knee arthroplasty; include pain control strategy, DVT prophylaxis, PT/OT milestones, wound status, bowel/urinary function, labs/vitals review, complications screening, and discharge readiness.

Draft a discharge summary for community-acquired pneumonia admission; include admission/discharge dates, presenting symptoms, radiology/labs, pathogen if identified, inpatient therapies and response, discharge medications with durations, pending tests, follow-up appointments, and return precautions.

Draft a discharge summary for myocardial infarction managed with PCI and drug-eluting stent placement; include cath findings, complications, inpatient course, discharge medications (DAPT, statin, beta-blocker, ACEi/ARB), cardiac rehab referral, and follow-up plan.

Draft discharge instructions for a patient hospitalized with acute decompensated heart failure; include daily weights, sodium and fluid restriction amounts, medication list with dosing, signs of worsening heart failure, follow-up appointments, and lab monitoring plan.

Draft discharge instructions for an asthma exacerbation; include controller and reliever regimen, steroid taper schedule, spacer technique, trigger avoidance, a written asthma action plan, return precautions, and follow-up timing.

Draft a patient handout on managing high blood pressure in plain language; explain what BP numbers mean, key lifestyle steps (DASH diet, sodium limits, alcohol moderation), home BP monitoring instructions, medication adherence tips, and when to call the doctor.

Draft a patient handout for type 2 diabetes education in plain language; cover A1c goals, the plate method, physical activity targets, self-monitoring of blood glucose, hypoglycemia signs and the 15-15 rule, foot care basics, and a vaccination checklist.

Draft a summary of the latest CDC and WHO guidelines for managing community-acquired pneumonia in adults, including empiric antibiotic choices, duration of therapy, and follow-up recommendations.

Draft a plain-language overview of the ADA and AACE guidelines for diabetes management, focusing on A1c goals, weight management, and the use of GLP-1 receptor agonists and SGLT2 inhibitors.

Draft a summary of the 2024 USPSTF breast cancer screening recommendations, including updated screening intervals, risk-based approaches, and the role of MRI for high-risk patients.

Draft a concise summary of NCCN guidelines for melanoma management, including staging, surgical margins, adjuvant therapy, and checkpoint inhibitor recommendations.

Draft treatment alternatives for community-acquired MRSA skin infections in patients allergic to sulfa drugs; include oral and IV options, dosing, and duration.

Draft treatment alternatives for patients with type 2 diabetes who are unable to tolerate GLP-1 receptor agonists due to nausea; include medication substitutions and lifestyle recommendations.

Draft a summary of options for treating refractory depression, comparing ketamine infusions, transcranial magnetic stimulation (TMS), and electroconvulsive therapy (ECT).

Draft treatment options for advanced prostate cancer, including hormonal therapy, radiopharmaceuticals, and novel androgen receptor pathway inhibitors.

Draft a summary of recent research on mRNA vaccine technology beyond COVID-19, including applications in oncology and autoimmune disease prevention.

Draft an easy-to-understand overview of long COVID research, summarizing major symptoms, hypothesized mechanisms, and emerging treatment approaches.

Draft a summary of current research on Alzheimer’s disease biomarkers, including amyloid and tau imaging, and discuss how they influence diagnosis and trial design.

Draft an explanation of the interaction between warfarin and antibiotics such as ciprofloxacin or TMP-SMX, including INR effects and management recommendations.

Draft a summary evaluating drug interactions for patients taking Paxlovid and common cardiovascular drugs; include mechanism and recommended dose adjustments.

Draft a summary of the common and serious side effects of semaglutide, including GI intolerance, gallbladder disease, and thyroid-related warnings.

Draft an overview of potential side effects associated with long-term corticosteroid use, including osteoporosis, glucose intolerance, and adrenal suppression.

Draft a summary of essential lab tests to order in suspected acute pancreatitis, including amylase, lipase, liver enzymes, and metabolic panels, with interpretation guidance.

Draft laboratory workup recommendations for suspected hypothyroidism, including TSH, free T4, thyroid antibodies, and when to consider secondary causes.

Draft an explanation of which labs should be monitored in patients receiving methotrexate therapy, including CBC, LFTs, renal function, and frequency of monitoring.

why choose us

Edit Geo

×

Course: 2024 Psychiatry Update

Released: 0000-00-00

Program Description
Click here to Register
Register now for our Psychiatry Update 2024 series, which includes multiple dates through the spring and summer! This free program is offered in a virtual format with up to 6.5 CME/CE credits.
Join fellow healthcare professionals from around the country for this popular series, now in its ninth year! Join us online to hear from our world-class faculty as they discuss the latest diagnostic and therapeutic strategies in psychiatry today.
Agenda
9:00 AM - 10:05 AM
Opening Remarks and Silent Struggles: Bridging Gaps in PTSD Care for a Holistic Healing Journey
Explore the frontiers of PTSD care in this session, which will shine a spotlight on the existing gaps in current PTSD treatment modalities, providing a critical examination of where the gaps lie and their impact on individuals. Delve into the promising realm of emerging management strategies as we discuss innovative approaches that hold the potential to reshape and enhance PTSD care.
10:10 AM - 11:10 AM
Non-CME Educational Session 1
11:15 AM - 12:15 PM
Restoring Serenity: Evidence-Based Strategies for Managing Agitation in Alzheimer's Disease
This session will delve into the complex realm of agitation associated with dementia due to Alzheimer’s disease, exploring its causes, impact, and effective management strategies. From unraveling the underlying triggers to discussing compassionate approaches, this session aims to equip healthcare professionals with the knowledge and tools needed to effectively manage the challenges of agitation in Alzheimer’s-related dementia.
12:20 PM - 1:20 PM
Approaching Weight Loss and Metabolic Issues in Psychiatry —presented by Robert O. Cotes, MD
1:25 PM - 2:25 PM
Non-CME Educational Session 2
2:30 PM - 3:30 PM
Beyond the First Line: Navigating the Crossroads of MDD Treatment Switching and Augmentation Strategies
When a patient with MDD does not respond to a first-line agent, it can be difficult to decide whether to switch or augment therapy. This session will cover the evidence for switching and augmenting treatment and include an overview of the evidence for augmentation agents in the treatment of MDD, reinforced through patient cases.
3:35 PM - 6:15 PM
Managing Pain and Opioid Use Disorder With Consideration for Both Physical and Psychiatric Manifestations and Closing Remarks—presented by Theresa Mallick-Searle, MS, PMGT-BC, ANP-BC, and Michael Weaver, MD, DFASAM
Join us for this comprehensive, 2.5-hour webinar covering pain management from head to toe. Through expert-led discussions on pain assessment, management options, and opioid use disorder, attendees will gain appreciation for and understanding of the biopsychosocial model of pain and addiction, helping to reinforce clinical strategies that will promote safe, effective, patient-centered care.
Target Audience
Physicians, registered nurses, pharmacists, social workers, and psychologists engaged in the care of patients with psychiatric illness
Commercial Supporter
This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please see
https://www.opioidanalgesicrems.com/Resources/Docs/List_of_RPC_Companies.pdf for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements.


Accredited Provider
Provided by Clinical Care Options, LLC in partnership with the Alliance to Advance Comprehensive Integrative Pain Management, the American Academy of Physical Medicine and Rehabilitation, Practicing Clinicians Exchange, and ProCE, LLC.
Joint Accreditation
In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
CCO designates this live activity for a maximum of 6.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Continuing Education
The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 6.5 contact hours, including 6.5 hours of pharmacotherapy credit.
Continuing Pharmacy Education
CCO designates this continuing education activity for 6.5 contact hours (0.65 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number - UAN will be specific to topics.
Type of Activity: Application
Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.
Physician Associate Continuing Medical Education
Clinical Care Options, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 6.5 AAPA Category 1 CME credits. PAs should only claim commensurate with the extent of their participation.
Psychologist Continuing Education
Continuing education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs.
This activity offers 6.5 continuing education credits for psychologists.
Social Worker Continuing Education
As a Jointly Accredited Organization, Clinical Care Options, LLC is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. Regulatory boards are the final authority on courses accepted for continuing education credit. Social workers completing this course receive 6.5 clinical continuing education credits.
Dental Professionals Continuing Education
Clinical Care Options, LLC is an ADA CERP Recognized Provider. ADA CERP is a service of the American
Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry. Concerns or complaints about a CE provider may be directed to the provider or to the Commission for Continuing Education Provider Recognition at ADA.org/CERP.
Clinical Care Options, LLC designates this activity for 2.5 continuing education credits.
Concerns or complaints about a CE provider may be directed to the provider, or to the Commission for Continuing Education Provider Recognition at ADA.org/CERP.
Optometrist Continuing Education
Clinical Care Options, LLC designates this asynchronous enduring activity for a maximum of 2.5 COPE credit hours. Optometrists should claim only the credit commensurate with the extent of their participation in the activity.
Additional Credit Information
ABMS Approval Statement
Through the American Board of Medical Specialties (“ABMS”) ongoing commitment to increase access to practice relevant Continuing Certification Activities through the ABMS Continuing Certification Directory, Tardive Dyskinesia, Silent Struggles: Bridging Gaps in PTSD Care For a Holistic Healing Journey, Beyond the First Line: Navigating the Crossroads of MDD Treatment – Switching and Augmentation Strategies, and Agitation Associated with Dementia due to Alzheimer’s Disease has met the requirements as a Lifelong Learning CME Activity (apply toward general CME requirement) for the following ABMS Member Boards:
Tardive Dyskinesia
ABMS Lifelong Learning CME Activity
Psychiatry and Neurology
Silent Struggles: Bridging Gaps in PTSD Care For a Holistic Healing Journey
ABMS Lifelong Learning CME Activity
Psychiatry and Neurology
Beyond the First Line: Navigating the Crossroads of MDD Treatment – Switching and Augmentation Strategies
ABMS Lifelong Learning CME Activity
Psychiatry and Neurology
Agitation Associated with Dementia due to Alzheimer’s Disease
ABMS Lifelong Learning CME Activity
Family Medicine
Psychiatry and Neurology
Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.


View Full Course

×
Chat & Ask Questions Career Openings Medical Doctors Check on Drug
Interactions Latest Health News
by WebHealthNetwork Get CME Credits Latest Clinical Trials Latest Research Articles Clinical Documents Update Profile

News

Chat

HCP Tools

Careers

Update Profile